Glymidine sodium 是口服有活性的抗糖尿病药物，也是肝脂肪分解的抑制剂。它通过抑制葡萄糖的形成，也对由于内源性脂质动员抑制而导致的丙酮酸氧化升高具有抑制作用。

Glymidine sodium is a sulfonamide hypoglycemic agent which stimulates insulin secretion.

3459-20-9

C13H15N3NaO4S

332.33

Glymidine sodium

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years